+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "T Cell Therapies"

Cell Cryopreservation Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cell Cryopreservation Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 146 Pages
  • Global
From
Cell Separation Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Cell Separation Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 145 Pages
  • Global
From
From
Cancer Gene Therapy Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Cancer Gene Therapy Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 152 Pages
  • Global
From
Global Gene Therapy Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Global Gene Therapy Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 152 Pages
  • Global
From
Global Gene Delivery Technologies Market - Product Thumbnail Image

Global Gene Delivery Technologies Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
From
Emerging Medical Technologies Spotlight - Product Thumbnail Image

Emerging Medical Technologies Spotlight

  • Newsletter
  • September 2024
  • Global
Loading Indicator

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease. T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more